Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 25 mg, 50 mg and 100 mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity found in the Active Pharmaceutical Ingredient (API)

Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 25 mg, 50 mg and 100 mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity found in the Active Pharmaceutical Ingredient (API)
Published: 2019-02-28

Get a Quote or Let Us Help You!

If you'd like to explore your insurance options, please visit our contact page or connect with a member of The Richards Group team at (262) 326-4750.

Get a Quote Today!

Enjoy this blog? Please spread the word :)

Facebook
LinkedIn
Twitter
Instagram
YouTube
Pinterest
Follow by Email
Google+
http://richardsgroupinsurance.com/feed-items/camber-pharmaceuticals-inc-issues-voluntary-nationwide-recall-of-losartan-potassium-tablets-usp-25-mg-50-mg-and-100-mg-due-to-the-detection-of-trace-amounts-of-n-nitroso-n-methyl-4-amino-butyric">
RSS
Follow Us on LinkedIn Follow Us on Twitter Subscribe to Us on YouTube Follow Us on Facebook